These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 712945)

  • 41. Phase I study of continuous-infusion cisplatin.
    Posner MR; Skarin AT; Clark J; Ervin TJ
    Cancer Treat Rep; 1986 Jul; 70(7):847-50. PubMed ID: 3013401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
    Glynne-Jones R; Hoskin P
    J Clin Oncol; 2007 Nov; 25(33):5281-6. PubMed ID: 18024876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hearing loss--risk factor for cisplatin ototoxicity? Observations.
    Durrant JD; Rodgers G; Myers EN; Johnson JT
    Am J Otol; 1990 Sep; 11(5):375-7. PubMed ID: 2240186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [First therapeutic experience with cis-platinum(II)diamindichloride (NSC 119875) in metastasizing ovarian and testicular carcinoma].
    Cavalli F; Sonntag RW; Ryssel HJ; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1976 May; 106(22):754-7. PubMed ID: 996494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs.
    Shapiro W; Kitchell BE; Fossum TW; Couto CG; Theilen G
    J Am Vet Med Assoc; 1988 Dec; 193(12):1530-3. PubMed ID: 3215812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cisplatinum compounds].
    Ota K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anticancer treatment and bromelains].
    Gerard G
    Agressologie; 1972; 13(4):261-74. PubMed ID: 4678520
    [No Abstract]   [Full Text] [Related]  

  • 49. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.
    Yagoda A; Watson RC; Gonzalez-Vitale JC; Grabstald H; Whitmore WF
    Cancer Treat Rep; 1976 Jul; 60(7):917-23. PubMed ID: 1009522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma.
    Huang YC; Chang PM; Chen MH; Chu PY; Tzeng CH; Chang SY; Yang MH
    Jpn J Clin Oncol; 2011 May; 41(5):630-6. PubMed ID: 21297121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    Walker MC; Parris CN; Masters JR
    J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neuropathies in cancer patients during chemotherapy with platinum preparations].
    Perevodchikova NI; Zavalishin IA; Adartseva LS; Sloka SA; Orel NF; Gorbunova VA; Brovtsyn VK
    Sov Med; 1991; (1):79-81. PubMed ID: 1862396
    [No Abstract]   [Full Text] [Related]  

  • 53. Comment on "Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis", by Rades et coll.
    Bossi P; Granata R; Bergamini C; Mirabile A; Locati L; Licitra L
    Oral Oncol; 2010 Dec; 46(12):888; author reply 889-90. PubMed ID: 20952248
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cisplatin and bleomycin in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck. A randomized facultative Phase III controlled study].
    Morton RP; Rugman F; Dorman EB; Stoney PJ; Wilson JA; McCormick M; Veevers A; Stell PM
    Sonderb Strahlenther Onkol; 1987; 81():141-50. PubMed ID: 2435009
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antiemetic therapy with timiperone in cisplatin-induced vomiting].
    Tari K; Satake I; Kojima S; Owada F
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2848-52. PubMed ID: 3753027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Taxotere in various solid tumors].
    Orel NF
    Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute vascular events associated with cisplatin therapy in malignant disease.
    Hennessy B; O'Connor M; Carney DN
    Ir Med J; 2002 May; 95(5):145-6, 148. PubMed ID: 12092697
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination chemotherapy in advanced head and neck cancer.
    Lorvidhaya V; Punpae P; Tonusin A; Sumitrasawan Y; Changwiwit W
    J Med Assoc Thai; 1986 Apr; 69(4):179-83. PubMed ID: 3723047
    [No Abstract]   [Full Text] [Related]  

  • 59. Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.
    Clarysse A; Kenis Y; Mathe G
    Recent Results Cancer Res; 1976; (53):1-552. PubMed ID: 189368
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump].
    Gestin-Boyer C; René C; Cupissol D; Tep A; Bressolle F; Bres J; Brun S; Serrou B; Pujol H
    C R Seances Soc Biol Fil; 1989; 183(3):263-8. PubMed ID: 2532561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.